01 7Gonax
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 47
2019 Revenue in Millions : 47
Growth (%) : 0
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 42
2020 Revenue in Millions : 46
Growth (%) : -2
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 37
2021 Revenue in Millions : 42
Growth (%) : -13
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 43
2017 Revenue in Millions : 42
Growth (%) : 2%
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 39
2015 Revenue in Millions : 34
Growth (%) : 13
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 47
2018 Revenue in Millions : 45
Growth (%) : 6
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 45
2016 Revenue in Millions : 41
Growth (%) : 9
